Deborah Arnott, ASH UK
(representing the Framework Convention Alliance)
Deborah Arnott is Chief Executive of Action on Smoking and Health (UK), honorary associate professor in the Division of Epidemiology and Public Health at the University of Nottingham, honorary fellow of the Royal College of Physicians and member of the RCP’s Tobacco Advisory Group. A recognised international expert on tobacco control and the WHO Framework Convention on Tobacco Control, she has a particular interest in nicotine regulation and harm reduction. She was a member of the NICE committee which developed the guidance on Tobacco Harm Reduction and of the Commission on Human Medicines expert advisory group to the MHRA on nicotine containing products, as well as being a civil society observer to the WHO FCTC Article 9 and 10 working group on tobacco product regulation. Previously Head of Consumer Education for the UK’s statutory financial services regulator the FSA, she also has experience as a journalist in print and television.
Clive Bates , Counterfactual Consulting, United Kingdom
Clive Bates has had varied career having worked in the private sector for IBM, in the UK government in Tony Blair's Strategy Unit, the United Nations in Sudan, for Greenpeace and for Action on Smoking and Health in the UK, which is why he is interested in smoke free alternatives to tobacco. Since early 2013 he has his own public interest consultancy and advocacy organisation, including the Counterfactual blog. He is interested in the enormous public health potential of tobacco harm reduction and is not engaged by pharmaceutical, e-cigarette or tobacco interests.
Prof Linda Bauld, University of Stirling and UK Centre for Tobacco and Alcohol Studies, UK
Linda Bauld is Professor of Health Policy at the University of Stirling, Director of the Institute for Social Marketing and Deputy Director of the UK Centre for Tobacco and Alcohol Studies. She has a background in applied policy research and for the past 15 years her research interests have centred on the evaluation of public health interventions. She has conducted studies on drug and alcohol use, inequalities in health and, most notably, on tobacco control and smoking cessation. She is a former scientific adviser on tobacco control to the UK government and currently chairs a number of public health advisory and funding committees for NICE, Cancer Research UK and the Scottish government.
Peter Beckett is a government relations practitioner who specialises in the political risk associated with emerging technology and disruptive innovation. He is Head of Public Policy at ECITA, the UK trade association for vapour companies, and worked on the the passage of new EU regulations for the category as part of the recently approved Tobacco Products Directive.
Cynthia Cabrera , SFATA (Smokefree Alternatives Trade Association), USA
Executive Director at Smoke-Free Alternatives Trade Association (SFATA). Since 2011 an expert in the burgeoning field of electronic cigarettes and personal electronic vaporizers. Cynthia is Lead Consultant and owner of Global Solutions & Services, Inc., a consulting firm dedicated to assisting companies and not for profit organizations in implementing Lean Management Principles in their native environments.
Dr Lynne Dawkins , School of Psychology, University of East London, United Kingdom
Dr Lynne Dawkins is an experimental psychologist and leader of the Drugs and Addictive Behaviours Research Group at UEL. She has over 15 years’ experience of working with smokers in research contexts and, more recently, with novice and experienced e-cigarette users. Dr Dawkins is one of the UK’s leading authorities on e-cigarettes having published papers on their utilisation, effects, and nicotine delivery. She has disseminated her findings widely via academic conference, public lectures and online media.
President, FIVAPE, French Vapor Trade Association: With an international background in marketing, communication and public relations, Arnaud heads the FIVAPE – the Interprofessional Vaping Federation. Bringing together more than 100 members, the FIVAPE represents the French professional vaping community, notably manufacturers, importers, producers of e-liquids as well as retailers. FIVAPE is based on three Secretary-Generals, representing manufacturers, distributors and vaper relations respectively. Our organisation advocates the interests of our sector towards public authorities and the general public, at both the French and the European levels.
Dr Mirosław Dworniczak , Scientific Journalist and Consultant, Poland
Doctor of chemistry, scientific advisor, science journalist, member of the Polish Association of Science Journalists "Naukowi.pl". Author (under the name "Stary Chemik" - "Old Chemist") of the first blog in Poland dealing
with e-cigarettes and e-liquid chemistry and safety - starychemik.wordpress.com
Dr Karl Fagerström , Smokers Information Center, Sweden
Karl is a licensed clinical psychologist with a PhD on nicotine dependence and smoking cessation, who started a smoking cessation clinic in 1975 and invented the Fagerstrom Test for Cigarette Dependence. In the 70s and 80s he served as the editor – in – chief for the Scandinavian Journal for Behaviour Therapy. Currently he works with his own private consultancy (Fagerstrom Consulting). He is a founding member of the Society for Research on Nicotine and Tobacco and currently a Deputy Editor of the Nicotine & Tobacco Research. He started the European SRNT affiliate in 1999. His main research contributions have been in the fields of Behaviour Medicine, Tobacco and Nicotine with over 160 peer reviewed publications of which he is the first author of 95.
The current main interest is on reducing harm and exposure to tobacco toxins. He was awarded the WHO medal 1999 for outstanding work in tobacco control and is the recipient of the 2013 Award on Clinical Science from the Society for Research on Tobacco and Nicotine.
Dr Konstantinos Farsalinos , Onassis Cardiac Surgery Center, Athens, Greece
Dr Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010.
He has been actively performing research on electronic cigarettes since 2011 as a principle investigator, in both clinical and laboratory level. Examples of his work include the first study on the cytotoxic effects of electronic cigarette vapor on cultured cells and the immediate effects of electronic cigarettes used on cardiac function and coronary circulation. He has presented his research in major international scientific congresses and has published more than 15 studies and letters about e-cigarettes in peer-reviewed medical journals.
Joseph (Joe) G. Gitchell serves as President at PinneyAssociates, with responsibility for client service, and leads the Marketing Strategy team. Mr. Gitchell leads efforts supporting regulatory approvals, conducting public policy analysis, developing marketing approaches, devising, refining and defending claims (including extensive claims challenge support) and providing input on strategic market opportunities and directions. He has worked for clients in the US, Europe, Latin America, Asia and the Middle East. This work has included extensive collaboration with researchers and policy experts around the world.
A co-author on almost 40 articles, Mr. Gitchell has been published in journals including Tobacco Control, Preventive Medicine, Addiction, Archives of Internal Medicine and Morbidity and Mortality Weekly Report.
Dr Maciej Goniewicz , Roswell Park Cancer Institute, Buffalo, USA
Dr. Maciej L. Goniewicz is an Assistant Professor of Oncology at the Department of Health Behavior, Roswell Park Cancer Institute in Buffalo. He earned a Pharm.D. degree (2002) and a Ph.D. in Toxicology and Pharmacology (2007) from the Medical University of Silesia, Poland. He completed his postdoctoral fellowships in Clinical Pharmacology and Tobacco Control at the University of California San Francisco and in Smoking Cessation Treatment in Queen Mary University of London, UK. Dr. Goniewicz has research experience in smoking cessation, pharmacotherapy, and pharmacokinetics. His current research is focused on new nicotine-containing products. These studies include the laboratory evaluation of the products, pharmacological and toxicological assessment, surveys among their users, and their potential application in harm reduction and smoking cessation.
Prof Peter Hajek , Queen Mary University, London, United Kingdom
Peter Hajek is Professor of Clinical Psychology, Head of Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. He has contributed to the establishment of the UK specialist stop-smoking service, training of its staff, and relevant NICE guidelines. He authored or co-authored over 280 publications on psychological treatments and on smoking cessation.
Charles Hamshaw-Thomas , Zandera Ltd, United Kingdom
Director of Legal & Corporate Affairs at E-Lites, one of the UK’s leading e-cig companies.
Hamshaw-Thomas has substantial senior executive experience as general counsel and corporate affairs director for some of the UK’s largest plc’s. With extensive experience of the political and regulatory environment surrounding smoking and tobacco, he has enabled E-Lites to take a prominent position over the last 18 months in the e-cig regulatory debate in Brussels and London. And, as principal of CSR Solutions, he is recognised as one of the UK’s leading environmental litter campaigners.
Dr Jacques le Houezec , Charter Member of SNRT, UK Centre for Tobacco Control Studies, University of Nottingham in England, Consultant, France
Trained neuroscientist in Paris (PhD in 1988) who spent 2 years as a post-doctoral fellow in Clinical Pharmacology & Experimental Therapeutics at the University of California. After 6 years of research in La Salpêtrière Hospital (Paris), and teaching at Paris V and Paris VII Universities, he became a freelance consultant for the pharmaceutical industry and the public sector (training smoking cessation specialists, and writing monthly scientific digests for them). He is a Charter Member of SRNT and was part of the core group who founded SRNT Europe. He participated in the Steering Committee of the WHO Europe Partnership Project to reduce Tobacco Dependence (1991-2001), and was also on the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCHENIR) expert group on smokeless tobacco (2006-2008). He is also Honorary Lecturer, UK Centre for Tobacco Control Studies, University of Nottingham, England, and manager of www.treatobacco.net the SRNT & SSA website dedicated to tobacco dependence treatment.
Dr Delon Human , Health Diplomats, Switzerland
Delon Human, M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA is the President and CEO of Nicolife, a group specializing in tobacco harm reduction and the appropriate use and recognition of nicotine. He is also currently the Secretary-General of the Africa Medical Association, a published author, international lecturer and well-respected health care consultant specialising in health system and product development, corporate and product transformation, strategy formulation and health communication. He has acted as adviser to the WHO Director-General and UN Secretary-General Ban Ki Moon.
Leon Kośmider , Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland
Pharmacist working as a scientist at the Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland, PhD student at the Department of Pharmacy in the Laboratory Medicine Unit of the Silesian University. Since 2007 Mr Kosmider worked in scientific club of the Department of General and Inorganic Chemistry at Medical University of Silesia. Mr Kośmider has been focusing on the analysis of tobacco smoke, risk associated with using traditional and e-cigarettes and the toxicity of smoke and aerosol. Mr Kosmider is an author or co-author of 40 academic conference speeches and 14 publications.
Prof Karl Lund, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway
Research Director at the Norwegian Institute for Alcohol and Drug Research since 2006. He has been involved in tobacco control work since the mid 1980s, working at the Norwegian Council on Tobacco or Health (Deputy Leader), the Norwegian Institute for Public Health (Researcher), and the Norwegian Cancer Society (Director for Department of Cancer Prevention). Dr. Lund received the Norwegian Medical Association’s Award in preventive medicine in 2002. He is well published within tobacco research, has been a lecturer on tobacco topics in several countries worldwide, and has been a member of several expert committees on tobacco control including WHO’s International Agency for Cancer Research (IARC) and the executive committee of the International Society for the Prevention of Tobacco Induced Diseases. He has also been an expert witness for the plaintiff in tort liability lawsuits brought before the Norwegian Supreme Court against the tobacco industry. Dr. Lund has been associate editor in the scientific journal Nicotine & Tobacco Research since 2011.
Hazel Mabe , Interessengemeinschaft E-Dampfen and European United Vapers Network, Germany
An active member of IG-ED e.V. since June 2013 and concerned with helping with the organisation’s publications in German and English as well as maintaining international relations. IG-ED e.V. is the first consumer organisation of German speaking vapers. It was established in 2011 and works voluntarily and independently of e-cigarette producers and retailers. The objective is to raise awareness about e-cigarettes and to advocate for a good regulatory framework.
Robert Mrówczyński , SUEP (Polish Vapers Association), Poland
Robert Mrówczyński smoked analog cigarettes for 40 years, since he was 12 and tried quitting using various methods, but without success. In December 2012 he switched to e-cigarettes and has been using them ever since. Robert is an active member of SUEP (Polish Vapers Association).
Tim Phillips is currently managing director of ECigIntelligence.com, an online independent professional market intelligence and regulatory tracking service for the electronic cigarette industry, providing objective analysis of the breakneck growth of this new sector. Tim has over 10 years of experience in regulation and business development in politically controversial sectors, having been Director of Public Affairs at Betfair, a market leading sports betting operator based in London, UK, which went through an IPO in 2010 valued at over £1.5bn.
After Tim graduated from Oxford University (Worcester College) with a BA in Earth Sciences in 1993, he went to law school in London and trained and practised corporate law at the European Commission in Brussels, and at international law firm Herbert Smith in London. Subsequently he ran the UK business development team at AOL Europe. He has founded and operated a number of internet start-up businesses in Buenos Aires, Argentina and London, UK in the internet sector. He was also part of the management team in a VC-backed start-up diamond recycling company based in New York, running the European business from offices in the UK and Spain, and the business’ online and marketing activities.
Most recently he founded ECigIntelligence to plug a knowledge gap for businesses in the electronic cigarette sector, providing independent analysis of news on market size and development, and regulatory landscape for this rapidly-growing consumer segment.
Prof Riccardo Polosa, Prof Riccardo Polosa , University of Catania, Italy
Director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy. He is also in charge of the University's Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK). He is author of more than 250 peer reviewed articles and books mainly covering respiratory medicine, clinical immunology, and tobacco addiction.
On top of his academic work, he serves also as chief scientific advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League. Prof Polosa's and his research team have lead several clinical trials on e-cigarettes.
Lars Ramström, Institute for Tobacco Studies, Sweden
Since 1990 Director of the Institute for Tobacco Studies, Stockholm, Sweden, an independent research institute focusing on the epidemiology of tobacco use and related policy matters. From 1967 to 1989 Director of the National Smoking and Health Association, a governmentally supported NGO dealing with tobacco control matters. Originally trained in natural science, thereafter supplementary studies in different tobacco-related sciences. International engagements with various organizations including periods of employment as consultant in WHO, participation in WHO Expert Committees, member of the WHO Expert Advisory Panel on Smoking and Health, Honorary Vice President of ICAA (International Council on Alcohol and Addictions) and chair of the ICAA Section on nicotine. Recipient of the 1988 WHO Award Medal for Achievements in Tobacco Control. Organizer and Secretary General of the Fourth World Conference on Smoking and Health in 1979. Author of articles in the scientific literature and reviewer for a number of medical science journals.
Lou Ritter , American E-Liquid Manufacturing Standards Association, USA
As elected President of the American E-liquid Manufacturing Standards Association (AEMSA), Lou Ritter serves as an unpaid volunteer. His Urban Planning background included functioning as a liaison between private and public sectors. After quitting smoking, using e-cigarette products, he committed to this opportunity to advance tobacco harm reduction. Lou has no financial involvement in the industry.
October 2012 - AEMSA launched as a nonprofit 501(c)(6) professional trade association establishing the world’s first (and only) self-regulation verifying e-liquid standards. AEMSA focuses on consumer protections, good product stewardship and advocacy. Members agree to various verifications including scheduled and unscheduled inspections and random product analysis. AEMSA has three highly credentialed SMEs and an established relationship with an accredited lab specializing in nicotine analysis.
AEMSA has presented before the USA FDA four times and met with OMB/OIRA (a division of the White House). AEMSA was co-founded, and formation facilitated, by unpaid consumer volunteers Linc Williams and Lou Ritter. AEMSA standards: http://www.aemsa.org/standards/
Prof Andrzej Sobczak , Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland
Prof . Andrzej Sobczak, head of the Department of General and Inorganic Chemistry at Medical University of Silesia and head of the Department of Chemical Hazards and Genetic Toxicology at the institute in Sosnowiec in Poland
Prof. Sobczak have been focusing on the toxicology of tobacco smoke for many years. Growing popularity of e-cigarettes led him to investigate these devices.
Prof Gerry Stimson , London School of Hygiene and Tropical Medicine, and Imperial College London, United Kingdom
A public health social scientist, with over 40 years’ experience of public health research and advocacy in the field of psychoactive substance use. He was one of the founders of harm reduction in the 1980s, and much of his academic research focused on reducing drug and alcohol related harms. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London, and the Editor of the International Journal of Drug Policy. He founded the Department of Social Science and Medicine at Imperial College. From 1990 to 2004, he was Director of the Centre for Research on Drugs and Health Behaviour. He was Executive Director of the International Harm Reduction Association from 2004 to 2010.
Rebecca Taylor, Member of European Parliament (MEP), United Kingdom
Rebecca Taylor is Liberal Democrat MEP for Yorkshire and the Humber since March 2012. Before being elected to the European Parliament, Rebecca worked in the health sector in a variety of roles including for the NHS, a health professional body, the pharmaceutical industry and a think-tank.
Rebecca is a member of the Legal Affairs (JURI) Committee and substitute member on the Environment, Public Health and Food Safety (ENVI) Committee and is very active on both committees. On the ENVI committee, Rebecca was the Liberal group shadow on cross-border health threats, In-Vitro diagnostic medical devices and healthy ageing, and was also very active on medical devices, clinical trials and the tobacco products directive.
Rebecca was one of the first MEPs with a health background to call for a consumer regulation of electronic cigarettes and along with other Liberal MEPs was instrumental in persuading the European Parliament to vote against medicines regulation of e-cigarettes. Rebecca remains convinced that e-cigarettes are a vital harm reduction tool for smokers, which should not be over-regulated, and that they have the potential to significantly reduce smoking related disease and death.
Atakan B. Tekin, THR Activist and Harm Reduction Entrepreneur
Atakan B. Tekin is a Turkish/European THR activist and Harm Reduction entrepreneur born in 1971. Atakan is an economist and business manager with a solid background in PR, Management, NGO fundraising, entrepreneurship, HACCP foodstuffs production, legal research and medical science research. Atakan is backed by a solid family background from the Pharmaceutical Industry as well as the Sciences of Health Economics. His focus area is affordable "THR" products aimed exclusively at established smokers in lower income brackets and also in the LMIC's over the next 30-50 years. Atakan is based in the Middle East.